Dynamic Assessment of the Risk for Language and Reading Disorders in Monolingual and Multilingual Children

Condition(s) studied

Investigational drug(s) / intervention(s)

computerized Dynamic Assessment: The DA tests (with a duration of about 30 minutes) can be administered by accessing the digital platform MuLiMi, individually with the experimenter or examiner. The tests are in game form and require children to learn the names of characters presented in the context of stories (preschool version) or to learn new codes for reading and writing (primary school version). In both cases, the new materials (names or codes) are repeatedly presented to the child until (s)he reaches an accuracy threshold. The number of repetitions needed to reach the threshold constitutes the main measure of the child's learning capacity, together with the number of errors committed during the various cycles.

Study summary

The project represents the completion of a part of the recently concluded European project MultiMind, in which a computer platform called MuLiMi was developed and validated. The platform hosts screening tests for the identification of the risk of Language and Learning Disorders in preschool and primary school children, respectively. The aim is to validate the Dynamic Assessment (DA) tests (a first test assessing the capacity to learn new words for preschool children and a second one assessing the capacity to learn a new spelling code for school-age children) in a population of monolingual and bilingual children attending preschool and primary school. The main goal of the study is to complete the validation of the two Dynamic Assessment tests implemented in the MuLiMi platform developed for the MultiMind project.

Eligibility

Primary outcome measure(s)

• accuracy during task performance — one or two days (one or two consecutive sessions depending on participant's age, collaboration and fatigue)
  total number and % correct answers, number and % errors during task performance
• efficiency during task performance — Intervention occurs during assessment: assessment will last one or two days (one or two consecutive sessions depending on participant's age, collaboration and fatigue)
  number of repeated cycles, number of cycles needed to reach target performance

Trial sites (1)

More IRCCS Eugenio Medea trials in Italy

Other trials for the same condition